Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT04659473
Other study ID # CovidSal01/2020
Secondary ID
Status Not yet recruiting
Phase
First received
Last updated
Start date December 9, 2020
Est. completion date December 20, 2020

Study information

Verified date December 2020
Source University of Salamanca
Contact Beatriz M Bermejo-Gil, Professor
Phone +34 622 289 468
Email beatriz.bermejo@usal.es
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Due to the pandemic situation, a rapid online survey may be the best method to assess and track people's pandemic cooping. Regarding the huge media influence and the government's restrictions to control the spread of covid-19; it is needed to know more about people's perception and situation to conduct future contentions plans. This study aims to apply a rapid online survey to determine the Spanish situation in this third wave of the pandemic. The survey will be delivered to 1000 participants to obtain a representative sample. It would be divided into six sections (general information, demography data, social and consuming habits, Covi-19 question, questions for Covid-19 positive, and questions for Covid-19 negative).


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 1000
Est. completion date December 20, 2020
Est. primary completion date December 20, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Owning online connection - Ability to answer and complete the survey Exclusion Criteria: - None

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Online survey
This study aims to apply a rapid online survey to determine the Spanish situation in this third wave of the pandemic.

Locations

Country Name City State
Spain Universidad de Salamanca Salamanca

Sponsors (1)

Lead Sponsor Collaborator
University of Salamanca

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary What's your work or study system nowadays? Multiple choice questionnaire 20 seconds
Primary Habits before the Covid-19 pandemic Likert scale questionnaire 60 seconds
Primary Habits in the Covid-19 pandemic Likert scale questionnaire 60 seconds
Primary Personal Covid-19 exposure and disease Dichotomous options questionnaire 10 seconds
Primary Positive Covid-19: tests, diagnosis, symptoms and quarantine Multiple choice questionnaire 60 seconds
Primary Negative Covid-19: tests and quarantine Multiple choice questionnaire 40 seconds
Primary Expectations Multiple choice questionnaire 10 seconds
Secondary Date of birth It is registered in the survey to know the age 20 seconds
Secondary Sex It is registered in the survey 20 seconds
Secondary Height It is registered in centimeters 20 seconds
Secondary Weight It is registered in kilograms 20 seconds
Secondary Blood type Multiple choice questionnaire 20 seconds
Secondary Pathologic history Multiple choice questionnaire 20 seconds
Secondary Region of residence Multiple choice questionnaire 20 seconds
Secondary City of residence Multiple choice questionnaire 20 seconds
Secondary Rural or urban environment Dichotomous options questionnaire 20 seconds
Secondary Cohabitants in the family unit The number of cohabitants is registered in the survey 20 seconds
See also
  Status Clinical Trial Phase
Completed NCT05047692 - Safety and Immunogenicity Study of AdCLD-CoV19-1: A COVID-19 Preventive Vaccine in Healthy Volunteers Phase 1
Recruiting NCT04395768 - International ALLIANCE Study of Therapies to Prevent Progression of COVID-19 Phase 2
Terminated NCT04555096 - A Trial of GC4419 in Patients With Critical Illness Due to COVID-19 Phase 2
Completed NCT04508777 - COVID SAFE: COVID-19 Screening Assessment for Exposure
Completed NCT04506268 - COVID-19 SAFE Enrollment N/A
Completed NCT04961541 - Evaluation of the Safety and Immunogenicity of Influenza and COVID-19 Combination Vaccine Phase 1/Phase 2
Active, not recruiting NCT04546737 - Study of Morphological, Spectral and Metabolic Manifestations of Neurological Complications in Covid-19 Patients N/A
Completed NCT04532294 - Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants Phase 1
Completed NCT04494646 - BARCONA: A Study of Effects of Bardoxolone Methyl in Participants With SARS-Corona Virus-2 (COVID-19) Phase 2
Terminated NCT04542993 - Can SARS-CoV-2 Viral Load and COVID-19 Disease Severity be Reduced by Resveratrol-assisted Zinc Therapy Phase 2
Not yet recruiting NCT04543006 - Persistence of Neutralizing Antibodies 6 and 12 Months After a Covid-19 N/A
Terminated NCT04581915 - PHRU CoV01 A Trial of Triazavirin (TZV) for the Treatment of Mild-moderate COVID-19 Phase 2/Phase 3
Completed NCT04537663 - Prevention Of Respiratory Tract Infection And Covid-19 Through BCG Vaccination In Vulnerable Older Adults Phase 4
Completed NCT04387292 - Ocular Sequelae of Patients Hospitalized for Respiratory Failure During the COVID-19 Epidemic N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Not yet recruiting NCT04527211 - Effectiveness and Safety of Ivermectin for the Prevention of Covid-19 Infection in Colombian Health Personnel Phase 3
Completed NCT04979858 - Reducing Spread of COVID-19 in a University Community Setting: Role of a Low-Cost Reusable Form-Fitting Fabric Mask N/A
Not yet recruiting NCT05038449 - Study to Evaluate the Efficacy and Safety of Colchicine Tablets in Patients With COVID-19 N/A
Completed NCT04610502 - Efficacy and Safety of Two Hyperimmune Equine Anti Sars-CoV-2 Serum in COVID-19 Patients Phase 2
Active, not recruiting NCT06042855 - ACTIV-6: COVID-19 Study of Repurposed Medications - Arm G (Metformin) Phase 3